Skip to main content
CivicGate

HR 5126
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

HIV Prevention Now Act

To provide funding for programs and activities of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for Disease Control and Prevention, and for other purposes.

Introduced Sep 4, 2025

Latest action (Sep 4, 2025) Referred to the House Committee on Appropriations.

Policy area
Issues
Healthcare

Summary

This bill appropriates $2,165,000,000 for fiscal year 2026 to the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention at the Centers for Disease Control and Prevention. The funding is provided in addition to other appropriations made to the Department of Health and Human Services and the CDC. The funds must be used exclusively for programs and activities of the center and cannot be transferred to any other entity.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Money behind the sponsor

Top reported contributors to Maxine Waters’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • GUSTAR KAPLAN NUSBAUM PLLC $9,900
  • INVARIANT $8,300
  • SLA WORLDWIDE $6,950
  • MINDSET $6,800
  • EGAN-JONES RATINGS CO. $6,600

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Maxine Waters → · Outside spending →

Actions (2)

  1. Sep 4, 2025 Referred to the House Committee on Appropriations. · house
  2. Sep 4, 2025 Introduced in House

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Text versions (1)

  • Introduced in House · Sep 4, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

September 4, 2025

Ms. Waters (for herself, Mr. Garcia of California, Mr. Nadler, Ms. Norton, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Garcia of Texas, Ms. Velazquez, Ms. Sewell, Mr. Carson, Mr. Jackson of Illinois, Ms. Titus, Mr. Johnson of Georgia, Mrs. McIver, Mrs. Beatty, Mr. Cleaver, Mr. Cohen, Ms. Wilson of Florida, Ms. Simon, Mr. Thanedar, Mr. Mullin, Mrs. Ramirez, Ms. Barragan, Mrs. Watson Coleman, Ms. Tlaib, Ms. Clarke of New York, and Ms. Williams of Georgia) introduced the following bill; which was referred to the Committee on Appropriations

A BILL

To provide funding for programs and activities of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for Disease Control and Prevention, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “HIV Prevention Now Act”.

SEC. 2. FUNDING FOR NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION.

(a) In General.—There is hereby appropriated for programs and activities of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for Disease Control and Prevention $2,165,000,000 for fiscal year 2026.

(b) Treatment of Funds.—Funds made available under subsection

(a)—

(1) shall be in addition to other amounts appropriated to the Department of Health and Human Services, including the Centers for Disease Control and Prevention;

(2) shall be used exclusively for the purposes specified in subsection (a); and

(3) may not be transferred to any entity other than the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention. <all>

Comments

Comments

Loading comments…